Kenanidis, Eustathios http://orcid.org/0000-0001-9517-1600
Boutos, Panagiotis
Voulgaris, Grigorios
Zgouridou, Aikaterini
Gkoura, Eleni
Gamie, Zakareya
Papagiannakis, George
Tsiridis, Eleftherios http://orcid.org/0000-0001-8278-1653
Funding for this research was provided by:
Aristotle University of Thessaloniki
Article History
Received: 3 October 2023
Accepted: 10 November 2023
First Online: 23 November 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The Institutional Review Board of A.U.Th. approved this prospective RCT (70/2023-15/02/2023). The study was registered in the Clinical Trials under the registration number NCT05807828.
: Informed consent was obtained from all individual participants included in the study.
: Ass. Prof. Kenanidis was a medical Developer of ORama VR and has received financial support from ORamaVR. Prof. Papagiannakis is the CEO and co-founder of ORamaVR. Prof Tsiridis is Co-founder of ORamaVR. The other authors have no relevant financial or non-financial interests to disclose.